Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
89.82B | 87.15B | 93.08B | 111.69B | 102.58B | Gross Profit |
89.82B | 87.15B | 93.08B | 111.69B | 102.58B | EBIT |
9.98B | 9.22B | 9.01B | 6.62B | 2.62B | EBITDA |
0.00 | -738.00M | 9.06B | 7.01B | 2.84B | Net Income Common Stockholders |
7.89B | 7.19B | 6.67B | 7.29B | 3.16B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
333.57B | 320.12B | 323.68B | 424.91B | 455.34B | Total Assets |
653.76B | 644.45B | 696.70B | 775.49B | 804.59B | Total Debt |
62.14B | 59.54B | 63.75B | 61.84B | 66.28B | Net Debt |
43.15B | 34.16B | 37.58B | 36.79B | 38.04B | Total Liabilities |
601.28B | 591.99B | 648.32B | 700.26B | 728.41B | Stockholders Equity |
49.94B | 49.58B | 45.35B | 71.13B | 71.61B |
Cash Flow | Free Cash Flow | |||
11.99B | 6.01B | 7.53B | 6.18B | 25.14B | Operating Cash Flow |
12.47B | 6.44B | 7.88B | 6.53B | 25.53B | Investing Cash Flow |
-11.25B | -1.59B | 470.00M | -8.95B | -11.43B | Financing Cash Flow |
-7.33B | -6.78B | -6.12B | -4.33B | -4.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $35.48B | 12.45 | 18.49% | 1.67% | 7.55% | 14.16% | |
76 Outperform | $105.09B | 12.72 | 16.16% | 5.05% | 6.84% | 11.87% | |
73 Outperform | $17.21B | 16.45 | 9.70% | 3.96% | 5.84% | -10.64% | |
73 Outperform | $33.64B | 9.17 | 18.42% | ― | 25.29% | -23.19% | |
70 Neutral | $11.21B | 15.88 | 9.36% | 4.91% | -5.03% | ― | |
68 Neutral | $48.60B | 18.84 | 6.13% | 1.90% | -44.30% | -33.09% | |
64 Neutral | $12.85B | 9.81 | 7.79% | 78.20% | 12.23% | -7.93% |